nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—PTGS1—Ifosfamide—testicular cancer	0.184	0.269	CbGbCtD
Sulfamethoxazole—CYP2C8—Ifosfamide—testicular cancer	0.106	0.155	CbGbCtD
Sulfamethoxazole—PTGS1—Etoposide—testicular cancer	0.0879	0.129	CbGbCtD
Sulfamethoxazole—CYP2C9—Ifosfamide—testicular cancer	0.074	0.108	CbGbCtD
Sulfamethoxazole—CYP2C8—Etoposide—testicular cancer	0.0507	0.0743	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—testicular cancer	0.0434	0.0635	CbGbCtD
Sulfamethoxazole—CYP3A4—Ifosfamide—testicular cancer	0.043	0.0631	CbGbCtD
Sulfamethoxazole—CYP2C9—Cisplatin—testicular cancer	0.036	0.0528	CbGbCtD
Sulfamethoxazole—CYP3A4—Vinblastine—testicular cancer	0.0228	0.0335	CbGbCtD
Sulfamethoxazole—CYP3A4—Etoposide—testicular cancer	0.0206	0.0301	CbGbCtD
Sulfamethoxazole—CYP3A4—Doxorubicin—testicular cancer	0.014	0.0206	CbGbCtD
Sulfamethoxazole—NAT1—seminal vesicle—testicular cancer	0.00119	0.31	CbGeAlD
Sulfamethoxazole—NAT1—female gonad—testicular cancer	0.0007	0.182	CbGeAlD
Sulfamethoxazole—NAT1—testis—testicular cancer	0.000621	0.162	CbGeAlD
Sulfamethoxazole—Cough—Etoposide—testicular cancer	0.000453	0.00144	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Cisplatin—testicular cancer	0.000453	0.00144	CcSEcCtD
Sulfamethoxazole—Asthenia—Bleomycin—testicular cancer	0.00045	0.00144	CcSEcCtD
Sulfamethoxazole—NAT1—lymph node—testicular cancer	0.00045	0.117	CbGeAlD
Sulfamethoxazole—Convulsion—Etoposide—testicular cancer	0.00045	0.00143	CcSEcCtD
Sulfamethoxazole—Skin disorder—Cisplatin—testicular cancer	0.000449	0.00143	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Doxorubicin—testicular cancer	0.000449	0.00143	CcSEcCtD
Sulfamethoxazole—Pruritus—Bleomycin—testicular cancer	0.000444	0.00142	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Methotrexate—testicular cancer	0.000442	0.00141	CcSEcCtD
Sulfamethoxazole—Nausea—Vinblastine—testicular cancer	0.000441	0.00141	CcSEcCtD
Sulfamethoxazole—Anorexia—Cisplatin—testicular cancer	0.000441	0.00141	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000439	0.0014	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000439	0.0014	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Methotrexate—testicular cancer	0.000438	0.0014	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000435	0.00139	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Dactinomycin—testicular cancer	0.000431	0.00138	CcSEcCtD
Sulfamethoxazole—Urticaria—Ifosfamide—testicular cancer	0.000426	0.00136	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Ifosfamide—testicular cancer	0.000424	0.00135	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Ifosfamide—testicular cancer	0.000424	0.00135	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Methotrexate—testicular cancer	0.000424	0.00135	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Etoposide—testicular cancer	0.000424	0.00135	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000421	0.00134	CcSEcCtD
Sulfamethoxazole—Ataxia—Doxorubicin—testicular cancer	0.00042	0.00134	CcSEcCtD
Sulfamethoxazole—Asthenia—Dactinomycin—testicular cancer	0.00042	0.00134	CcSEcCtD
Sulfamethoxazole—Neutropenia—Methotrexate—testicular cancer	0.000417	0.00133	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Etoposide—testicular cancer	0.000415	0.00132	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Epirubicin—testicular cancer	0.000414	0.00132	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Cisplatin—testicular cancer	0.000412	0.00132	CcSEcCtD
Sulfamethoxazole—Skin disorder—Etoposide—testicular cancer	0.000412	0.00131	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Epirubicin—testicular cancer	0.000409	0.00131	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Methotrexate—testicular cancer	0.000407	0.0013	CcSEcCtD
Sulfamethoxazole—Anorexia—Etoposide—testicular cancer	0.000404	0.00129	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000403	0.00128	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Cisplatin—testicular cancer	0.000402	0.00128	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dactinomycin—testicular cancer	0.000401	0.00128	CcSEcCtD
Sulfamethoxazole—Pneumonia—Methotrexate—testicular cancer	0.0004	0.00128	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000399	0.00127	CcSEcCtD
Sulfamethoxazole—Vomiting—Bleomycin—testicular cancer	0.000399	0.00127	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—testicular cancer	0.000398	0.00127	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—testicular cancer	0.000398	0.00127	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—testicular cancer	0.000397	0.00127	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Epirubicin—testicular cancer	0.000397	0.00126	CcSEcCtD
Sulfamethoxazole—Rash—Bleomycin—testicular cancer	0.000396	0.00126	CcSEcCtD
Sulfamethoxazole—Dermatitis—Bleomycin—testicular cancer	0.000395	0.00126	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Ifosfamide—testicular cancer	0.000395	0.00126	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000395	0.00126	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—testicular cancer	0.000391	0.00125	CcSEcCtD
Sulfamethoxazole—Neutropenia—Epirubicin—testicular cancer	0.000391	0.00125	CcSEcCtD
Sulfamethoxazole—Stomatitis—Methotrexate—testicular cancer	0.000388	0.00124	CcSEcCtD
Sulfamethoxazole—Asthenia—Ifosfamide—testicular cancer	0.000385	0.00123	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—testicular cancer	0.000383	0.00122	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Epirubicin—testicular cancer	0.000381	0.00122	CcSEcCtD
Sulfamethoxazole—Pruritus—Ifosfamide—testicular cancer	0.00038	0.00121	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—testicular cancer	0.000379	0.00121	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Etoposide—testicular cancer	0.000378	0.0012	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—testicular cancer	0.000376	0.0012	CcSEcCtD
Sulfamethoxazole—Pneumonia—Epirubicin—testicular cancer	0.000375	0.00119	CcSEcCtD
Sulfamethoxazole—Nausea—Bleomycin—testicular cancer	0.000373	0.00119	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Epirubicin—testicular cancer	0.000372	0.00119	CcSEcCtD
Sulfamethoxazole—Infestation—Epirubicin—testicular cancer	0.000372	0.00119	CcSEcCtD
Sulfamethoxazole—Vomiting—Dactinomycin—testicular cancer	0.000372	0.00119	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—testicular cancer	0.000371	0.00118	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000369	0.00118	CcSEcCtD
Sulfamethoxazole—Rash—Dactinomycin—testicular cancer	0.000369	0.00118	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Etoposide—testicular cancer	0.000368	0.00117	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Ifosfamide—testicular cancer	0.000367	0.00117	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—testicular cancer	0.000367	0.00117	CcSEcCtD
Sulfamethoxazole—Renal failure—Epirubicin—testicular cancer	0.000366	0.00117	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Etoposide—testicular cancer	0.000366	0.00117	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Cisplatin—testicular cancer	0.000366	0.00117	CcSEcCtD
Sulfamethoxazole—Fatigue—Etoposide—testicular cancer	0.000365	0.00117	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Epirubicin—testicular cancer	0.000365	0.00116	CcSEcCtD
Sulfamethoxazole—Stomatitis—Epirubicin—testicular cancer	0.000363	0.00116	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—testicular cancer	0.000361	0.00115	CcSEcCtD
Sulfamethoxazole—Hepatitis—Methotrexate—testicular cancer	0.000357	0.00114	CcSEcCtD
Sulfamethoxazole—Dizziness—Ifosfamide—testicular cancer	0.000355	0.00113	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—testicular cancer	0.000353	0.00113	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000353	0.00112	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Epirubicin—testicular cancer	0.000352	0.00112	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—testicular cancer	0.00035	0.00112	CcSEcCtD
Sulfamethoxazole—Nausea—Dactinomycin—testicular cancer	0.000348	0.00111	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Epirubicin—testicular cancer	0.000348	0.00111	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—testicular cancer	0.000347	0.00111	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Etoposide—testicular cancer	0.000346	0.0011	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—testicular cancer	0.000345	0.0011	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—testicular cancer	0.000345	0.0011	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000342	0.00109	CcSEcCtD
Sulfamethoxazole—Vomiting—Ifosfamide—testicular cancer	0.000341	0.00109	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Cisplatin—testicular cancer	0.000341	0.00109	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—testicular cancer	0.000339	0.00108	CcSEcCtD
Sulfamethoxazole—Rash—Ifosfamide—testicular cancer	0.000338	0.00108	CcSEcCtD
Sulfamethoxazole—Dermatitis—Ifosfamide—testicular cancer	0.000338	0.00108	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—testicular cancer	0.000338	0.00108	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000338	0.00108	CcSEcCtD
Sulfamethoxazole—Urticaria—Etoposide—testicular cancer	0.000337	0.00107	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—testicular cancer	0.000336	0.00107	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Etoposide—testicular cancer	0.000335	0.00107	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Etoposide—testicular cancer	0.000335	0.00107	CcSEcCtD
Sulfamethoxazole—Hepatitis—Epirubicin—testicular cancer	0.000334	0.00107	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—testicular cancer	0.000334	0.00106	CcSEcCtD
Sulfamethoxazole—Tinnitus—Methotrexate—testicular cancer	0.000333	0.00106	CcSEcCtD
Sulfamethoxazole—Asthenia—Cisplatin—testicular cancer	0.000332	0.00106	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Epirubicin—testicular cancer	0.00033	0.00105	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Epirubicin—testicular cancer	0.000329	0.00105	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Epirubicin—testicular cancer	0.000328	0.00105	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000326	0.00104	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—testicular cancer	0.000323	0.00103	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—testicular cancer	0.000322	0.00103	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000322	0.00103	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—testicular cancer	0.000321	0.00102	CcSEcCtD
Sulfamethoxazole—Nausea—Ifosfamide—testicular cancer	0.000319	0.00102	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Cisplatin—testicular cancer	0.000316	0.00101	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Epirubicin—testicular cancer	0.000316	0.00101	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—testicular cancer	0.000313	0.000998	CcSEcCtD
Sulfamethoxazole—Eye disorder—Epirubicin—testicular cancer	0.000312	0.000996	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Etoposide—testicular cancer	0.000312	0.000996	CcSEcCtD
Sulfamethoxazole—Tinnitus—Epirubicin—testicular cancer	0.000312	0.000994	CcSEcCtD
Sulfamethoxazole—Malnutrition—Methotrexate—testicular cancer	0.000311	0.000992	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—testicular cancer	0.000309	0.000987	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000305	0.000974	CcSEcCtD
Sulfamethoxazole—Asthenia—Etoposide—testicular cancer	0.000304	0.00097	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000304	0.000969	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—testicular cancer	0.000303	0.000967	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Epirubicin—testicular cancer	0.000302	0.000963	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Epirubicin—testicular cancer	0.000301	0.000961	CcSEcCtD
Sulfamethoxazole—Chills—Epirubicin—testicular cancer	0.0003	0.000957	CcSEcCtD
Sulfamethoxazole—Pruritus—Etoposide—testicular cancer	0.0003	0.000956	CcSEcCtD
Sulfamethoxazole—Vomiting—Cisplatin—testicular cancer	0.000294	0.000938	CcSEcCtD
Sulfamethoxazole—Mental disorder—Epirubicin—testicular cancer	0.000293	0.000934	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—testicular cancer	0.000292	0.000933	CcSEcCtD
Sulfamethoxazole—Rash—Cisplatin—testicular cancer	0.000292	0.00093	CcSEcCtD
Sulfamethoxazole—Dermatitis—Cisplatin—testicular cancer	0.000291	0.000929	CcSEcCtD
Sulfamethoxazole—Malnutrition—Epirubicin—testicular cancer	0.000291	0.000928	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Etoposide—testicular cancer	0.00029	0.000925	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—testicular cancer	0.000289	0.000922	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—testicular cancer	0.000288	0.00092	CcSEcCtD
Sulfamethoxazole—Tension—Epirubicin—testicular cancer	0.000286	0.000911	CcSEcCtD
Sulfamethoxazole—Nervousness—Epirubicin—testicular cancer	0.000283	0.000901	CcSEcCtD
Sulfamethoxazole—Dizziness—Etoposide—testicular cancer	0.00028	0.000894	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—testicular cancer	0.000279	0.000891	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—testicular cancer	0.000279	0.000891	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—testicular cancer	0.000279	0.000889	CcSEcCtD
Sulfamethoxazole—Leukopenia—Methotrexate—testicular cancer	0.000278	0.000888	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—testicular cancer	0.000278	0.000885	CcSEcCtD
Sulfamethoxazole—Nausea—Cisplatin—testicular cancer	0.000275	0.000876	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—testicular cancer	0.000271	0.000865	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—testicular cancer	0.000271	0.000864	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—testicular cancer	0.000269	0.000859	CcSEcCtD
Sulfamethoxazole—Vomiting—Etoposide—testicular cancer	0.000269	0.000859	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—testicular cancer	0.000269	0.000859	CcSEcCtD
Sulfamethoxazole—Rash—Etoposide—testicular cancer	0.000267	0.000852	CcSEcCtD
Sulfamethoxazole—Dermatitis—Etoposide—testicular cancer	0.000267	0.000851	CcSEcCtD
Sulfamethoxazole—Headache—Etoposide—testicular cancer	0.000265	0.000847	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—testicular cancer	0.000265	0.000844	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—testicular cancer	0.000265	0.000844	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—testicular cancer	0.000264	0.000843	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000263	0.000839	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—testicular cancer	0.000262	0.000834	CcSEcCtD
Sulfamethoxazole—Vertigo—Epirubicin—testicular cancer	0.000261	0.000834	CcSEcCtD
Sulfamethoxazole—Leukopenia—Epirubicin—testicular cancer	0.00026	0.000831	CcSEcCtD
Sulfamethoxazole—Cough—Epirubicin—testicular cancer	0.000254	0.00081	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—testicular cancer	0.000254	0.000809	CcSEcCtD
Sulfamethoxazole—Convulsion—Epirubicin—testicular cancer	0.000252	0.000804	CcSEcCtD
Sulfamethoxazole—Nausea—Etoposide—testicular cancer	0.000252	0.000803	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—testicular cancer	0.000249	0.000794	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000248	0.000793	CcSEcCtD
Sulfamethoxazole—Myalgia—Epirubicin—testicular cancer	0.000248	0.00079	CcSEcCtD
Sulfamethoxazole—Arthralgia—Epirubicin—testicular cancer	0.000248	0.00079	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methotrexate—testicular cancer	0.000247	0.000786	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000246	0.000785	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—testicular cancer	0.000242	0.000772	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—testicular cancer	0.000242	0.000772	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—testicular cancer	0.000241	0.000769	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Epirubicin—testicular cancer	0.000238	0.000757	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—testicular cancer	0.000235	0.000749	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—testicular cancer	0.000233	0.000744	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Epirubicin—testicular cancer	0.000233	0.000743	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Epirubicin—testicular cancer	0.000233	0.000742	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000231	0.000737	CcSEcCtD
Sulfamethoxazole—Skin disorder—Epirubicin—testicular cancer	0.000231	0.000736	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—testicular cancer	0.00023	0.000732	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—testicular cancer	0.000229	0.000731	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—testicular cancer	0.000229	0.000731	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000228	0.000726	CcSEcCtD
Sulfamethoxazole—Anorexia—Epirubicin—testicular cancer	0.000226	0.000722	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—testicular cancer	0.000226	0.000722	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methotrexate—testicular cancer	0.000223	0.000712	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—testicular cancer	0.000221	0.000704	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—testicular cancer	0.00022	0.000701	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000219	0.000699	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—testicular cancer	0.000219	0.000698	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000216	0.00069	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—testicular cancer	0.000216	0.000687	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—testicular cancer	0.000215	0.000686	CcSEcCtD
Sulfamethoxazole—Insomnia—Epirubicin—testicular cancer	0.000215	0.000685	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—testicular cancer	0.000213	0.000681	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Epirubicin—testicular cancer	0.000212	0.000675	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—testicular cancer	0.000209	0.000668	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Epirubicin—testicular cancer	0.000209	0.000667	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—testicular cancer	0.000208	0.000662	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Epirubicin—testicular cancer	0.000206	0.000658	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000205	0.000654	CcSEcCtD
Sulfamethoxazole—Fatigue—Epirubicin—testicular cancer	0.000205	0.000653	CcSEcCtD
Sulfamethoxazole—Urticaria—Methotrexate—testicular cancer	0.000202	0.000643	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methotrexate—testicular cancer	0.000201	0.00064	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—testicular cancer	0.000201	0.00064	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.0002	0.000639	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—testicular cancer	0.000199	0.000634	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—testicular cancer	0.000196	0.000625	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Epirubicin—testicular cancer	0.000194	0.000619	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—testicular cancer	0.000193	0.000617	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—testicular cancer	0.000191	0.000609	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00019	0.000605	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—testicular cancer	0.000189	0.000604	CcSEcCtD
Sulfamethoxazole—Urticaria—Epirubicin—testicular cancer	0.000189	0.000602	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Epirubicin—testicular cancer	0.000188	0.000599	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Epirubicin—testicular cancer	0.000188	0.000599	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methotrexate—testicular cancer	0.000187	0.000596	CcSEcCtD
Sulfamethoxazole—PTGS1—seminal vesicle—testicular cancer	0.000186	0.0485	CbGeAlD
Sulfamethoxazole—Asthenia—Methotrexate—testicular cancer	0.000182	0.000581	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00018	0.000573	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—testicular cancer	0.00018	0.000573	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Epirubicin—testicular cancer	0.000175	0.000558	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—testicular cancer	0.000175	0.000557	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—testicular cancer	0.000174	0.000554	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—testicular cancer	0.000174	0.000554	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methotrexate—testicular cancer	0.000174	0.000554	CcSEcCtD
Sulfamethoxazole—Asthenia—Epirubicin—testicular cancer	0.00017	0.000543	CcSEcCtD
Sulfamethoxazole—ALB—testis—testicular cancer	0.00017	0.0443	CbGeAlD
Sulfamethoxazole—Pruritus—Epirubicin—testicular cancer	0.000168	0.000536	CcSEcCtD
Sulfamethoxazole—Dizziness—Methotrexate—testicular cancer	0.000168	0.000535	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Epirubicin—testicular cancer	0.000163	0.000518	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—testicular cancer	0.000162	0.000516	CcSEcCtD
Sulfamethoxazole—Vomiting—Methotrexate—testicular cancer	0.000161	0.000515	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—testicular cancer	0.00016	0.00051	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—testicular cancer	0.00016	0.00051	CcSEcCtD
Sulfamethoxazole—Headache—Methotrexate—testicular cancer	0.000159	0.000507	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—testicular cancer	0.000158	0.000503	CcSEcCtD
Sulfamethoxazole—Dizziness—Epirubicin—testicular cancer	0.000157	0.000501	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—testicular cancer	0.000155	0.000496	CcSEcCtD
Sulfamethoxazole—Vomiting—Epirubicin—testicular cancer	0.000151	0.000482	CcSEcCtD
Sulfamethoxazole—Nausea—Methotrexate—testicular cancer	0.000151	0.000481	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—testicular cancer	0.00015	0.00048	CcSEcCtD
Sulfamethoxazole—Rash—Epirubicin—testicular cancer	0.00015	0.000478	CcSEcCtD
Sulfamethoxazole—Dermatitis—Epirubicin—testicular cancer	0.00015	0.000477	CcSEcCtD
Sulfamethoxazole—Headache—Epirubicin—testicular cancer	0.000149	0.000475	CcSEcCtD
Sulfamethoxazole—Dizziness—Doxorubicin—testicular cancer	0.000145	0.000463	CcSEcCtD
Sulfamethoxazole—Nausea—Epirubicin—testicular cancer	0.000141	0.00045	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—testicular cancer	0.00014	0.000446	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—testicular cancer	0.000139	0.000442	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—testicular cancer	0.000138	0.000442	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—testicular cancer	0.000138	0.000439	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—testicular cancer	0.000131	0.000416	CcSEcCtD
Sulfamethoxazole—ALB—lymph node—testicular cancer	0.000123	0.0321	CbGeAlD
Sulfamethoxazole—CYP2C8—testis—testicular cancer	0.000119	0.0311	CbGeAlD
Sulfamethoxazole—PTGS1—female gonad—testicular cancer	0.000109	0.0285	CbGeAlD
Sulfamethoxazole—PTGS1—testis—testicular cancer	9.69e-05	0.0252	CbGeAlD
Sulfamethoxazole—PTGS1—lymph node—testicular cancer	7.02e-05	0.0183	CbGeAlD
